Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials.
about
Proteomic dissection of cell type-specific H2AX-interacting protein complex associated with hepatocellular carcinomaRegulators of Actin Dynamics in Gastrointestinal Tract TumorsComprehensive fluorogenic derivatization-liquid chromatography/tandem mass spectrometry proteomic analysis of colorectal cancer cell to identify biomarker candidate.From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis.Protein profile of human hepatocarcinoma cell line SMMC-7721: identification and functional analysisProteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network.Bioinformatics analysis of metastasis-related proteins in hepatocellular carcinomaO Labeling for a Quantitative Proteomic Analysis of Glycoproteins in Hepatocellular Carcinoma.Proteomics for the discovery of nuclear bile acid receptor FXR targetsOncolytic adenovirus SG600-IL24 selectively kills hepatocellular carcinoma cell lines.Calreticulin expression in infiltrating ductal breast carcinomas: relationships with disease progression and humoral immune responses.Non-alcoholic fatty liver disease proteomicsThe cofilin pathway in breast cancer invasion and metastasisDynamic expression patterns of differential proteins during early invasion of hepatocellular carcinoma.Changes in tumor growth and metastatic capacities of J82 human bladder cancer cells suppressed by down-regulation of calreticulin expression.Morphogenesis of the mouse neural plate depends on distinct roles of cofilin 1 in apical and basal epithelial domains.Blockage of TGFβ-SMAD2 by demethylation-activated miR-148a is involved in caffeic acid-induced inhibition of cancer stem cell-like properties in vitro and in vivo.Role of the cofilin activity cycle in astrocytoma migration and invasion.Silencing thioredoxin induces liver cancer cell senescence under hypoxia.The actin cytoskeleton as a sensor and mediator of apoptosisThe scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs)PX-12 inhibits the growth of hepatocelluar carcinoma by inducing S-phase arrest, ROS-dependent apoptosis and enhances 5-FU cytotoxicity.Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancerIdentification of Differential Protein Expression in Hepatocellular Carcinoma Induced Wistar Albino Rats by 2D Electrophoresis and MALDI-TOF-MS AnalysisInterferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma.CDK1 phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation.New approaches to targeting the actin cytoskeleton for chemotherapy.Glycosylation and liver cancer.Screening and identification of the tumor-associated antigen CK10, a novel potential liver cancer marker.MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma.Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma.Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis.Nano-LC-MS/MS based proteomics of hepatocellular carcinoma cells compared to Chang liver cells and tanshinone IIA induction.Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells.Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer.Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation.An update on the mouse liver proteome.Discovery of NKCC1 as a potential therapeutic target to inhibit hepatocellular carcinoma cell growth and metastasis.
P2860
Q22001505-DACC8B4E-F5B2-495C-9FC4-4B557F37C708Q26783246-B9C3FC3B-4465-44FA-94CE-0994C186191FQ31092607-6B177268-E1BD-4862-A807-4705BA2D68D8Q33194407-CB6C2210-0C0B-4755-BBD0-00EB10119485Q33286842-93A5D36A-FD40-439E-969D-7174D96B28D1Q33312899-CAE2D389-F697-4F0B-BB1C-4050BFB36816Q33376050-8E968B8D-8413-4D59-83B1-839908AA5469Q33760930-D31774D7-7E78-4AF8-86BE-9DC02FA90C16Q33856588-93B367C7-D1AF-4EE0-84A1-31140044E6AAQ34183175-88F79E63-8FD3-4BDF-9A5F-CF404D9D867FQ34555318-CEA20934-A863-4E97-A3BA-FE096A9319FAQ34578790-3DA63B83-A596-4035-9E4E-367F81445DF6Q34729399-00DF2437-C4D7-46FA-B791-DC4FD5679733Q35116051-0623979F-9782-46E0-B041-5CB2B5CAE5FEQ35168250-3C698D57-A3FC-4C8C-9A2B-FCB5440F6F70Q35228886-33AF01C4-2804-4140-8BB1-BD751A3229E1Q35763804-D9E7F35C-5F5B-405D-A1A6-D4AAD09A0721Q35959721-72DEFA53-ECDD-4215-9040-A8D7CFAD0D9BQ36028185-D50FE043-8ACC-4ECF-BB36-94BB9D7F327BQ36149204-EDBE6F23-459E-4D60-B3E9-7D4E1E305EABQ36152438-B49B4401-487D-4F9B-ADF4-D5C1BA14D531Q36225827-91BA4063-2F4E-464C-BD62-18A3A87FC9DCQ36381459-89FF1A49-B153-41E8-AFDE-F1FBB21B6839Q36764154-E000E7B0-EFBE-4F76-ADB5-923790CC31B4Q36971961-3EB6AC64-04CA-4729-9B4C-4ACBF42A04CAQ37388129-E1A478AC-E349-47E7-A1BB-A61FE82671EEQ37855886-914DC000-8706-4654-A0BD-4BE92807EBAEQ38366329-79F9D869-35F7-4D66-92F9-9ADC811BF030Q38704948-98A59C87-21EE-4299-91D0-1F8FBC2052B6Q38851568-211B91D0-8AEC-4CE8-B079-21CF24321996Q39038889-B50D3E9E-416C-49FA-B070-5F6C046BD127Q39124908-E46E64FA-3F1F-4FF1-B4C0-AF64A3B808CAQ39273360-33579F9C-BA96-40E5-891B-C563937F1D31Q39563873-38E55EF6-2C5D-47CA-9EAA-7C29D6BE856FQ39572850-1700C1A1-577F-488D-8FA2-7FB2B0F39314Q39625978-A5F1DDDE-3089-4471-B116-679E8BC8DAECQ40302198-0469C653-F7B7-44FD-A789-074EB7102A84Q40506655-8A1B2556-505D-424A-B42E-F4C02C7A6C2BQ42245165-4C7ED58F-C6D9-474D-9266-59DD19EBA21FQ42371633-AABF7C1E-083D-4428-9460-358A0B73F1F2
P2860
Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Proteome analysis of hepatocel ...... fferent metastasis potentials.
@ast
Proteome analysis of hepatocel ...... fferent metastasis potentials.
@en
type
label
Proteome analysis of hepatocel ...... fferent metastasis potentials.
@ast
Proteome analysis of hepatocel ...... fferent metastasis potentials.
@en
prefLabel
Proteome analysis of hepatocel ...... fferent metastasis potentials.
@ast
Proteome analysis of hepatocel ...... fferent metastasis potentials.
@en
P2093
P356
P1433
P1476
Proteome analysis of hepatocel ...... fferent metastasis potentials.
@en
P2093
Qi-Chang Xia
Shi-Jian Ding
Xiao-Xia Shao
Zhao-You Tang
P304
P356
10.1002/PMIC.200300653
P577
2004-04-01T00:00:00Z